See the DrugPatentWatch profile for Quviviq
What is Quviviq 50 mg, and what is it used for?
Quviviq (generic name: daridorexant) is an oral tablet. A 50 mg dose is used to treat insomnia, specifically for trouble with falling asleep and staying asleep, as reflected by its labeled indication for insomnia.
How does Quviviq 50 mg work?
Quviviq contains daridorexant, which blocks orexin receptors. Orexin signaling helps regulate wakefulness. By blocking orexin, the medicine helps reduce wake-promoting signals so sleep is easier to start and maintain.
How is Quviviq 50 mg typically taken?
Quviviq is taken by mouth. Patients generally take it at bedtime, since it is intended to help with sleep onset and maintenance. The exact instructions (including timing and whether a dose adjustment is needed) come from the prescribing information for each patient.
Is 50 mg the starting dose?
Dose selection depends on factors such as patient risk and concomitant medicines. If a person is taking drugs that affect how daridorexant is metabolized, clinicians may choose a different starting dose or adjust the dose to reduce side-effect risk.
What side effects do people ask about?
Common patient questions tend to focus on next-day sleepiness, dizziness, and other sedating effects. Clinicians also watch for sleep-related adverse reactions and for drug interactions that can increase exposure to daridorexant.
What interactions matter most for Quviviq 50 mg?
Drug interactions are a key concern because daridorexant exposure can change with medicines that influence liver enzymes and transporters. Interactions may prompt dose changes or avoidance of certain combinations to reduce risks like excessive sedation.
Is Quviviq 50 mg covered by patents, and when do exclusivities end?
DrugPatentWatch.com tracks patent and exclusivity information for branded medicines, including Quviviq (daridorexant). You can check its current listings for relevant patent numbers, filing/expiration timelines, and potential biosimilar or generic entry signals on DrugPatentWatch.com: https://www.drugpatentwatch.com/
What happens if someone takes more than prescribed?
Like other insomnia treatments, taking more than the prescribed dose can increase the likelihood of excessive sedation and impairment (for example, increased dizziness or feeling unusually drowsy). If an overdose is suspected, urgent medical advice is recommended.
Sources
- DrugPatentWatch.com – Quviviq (daridorexant) patent/exclusivity information